English

Cellu Tissue Holdings, Inc.

EDGAR

Registration statement (S-4) · filed 2013-06-04

33 filing records in this dataset, filed from 2004-11-15 to 2013-06-04. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

269 million USD

2010-08-26 · USD

Exact inputs and evidence

Revenue: 268736228 USD Source

Operating margin

2.93%

2010-08-26 · %

Exact inputs and evidence

Operating Income: 7868514 USD Source
Revenue: 268736228 USD Source

Cash and cash equivalents: 2.23 million USD 2010-08-26 Source
Exact value

2229594 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2013-06-04.

Financial data available through: 2010-02-28.

Financial coverage is incomplete. Newer filings are recorded, but comparable financial figures for those periods are not available here yet.

Coverage by financial measure

Revenue: 8 of 11 periods available· newest 2010-02-28
Operating income: 8 of 11 periods available· newest 2010-02-28
Net income: 8 of 11 periods available· newest 2010-02-28
Operating cash flow: 8 of 11 periods available· newest 2010-02-28
Capital expenditure: 8 of 11 periods available· newest 2010-02-28
Total assets: 7 of 11 periods available· newest 2010-02-28
liabilities: No compatible figures in this window
Current assets: 7 of 11 periods available· newest 2010-02-28
Current liabilities: 7 of 11 periods available· newest 2010-02-28
Cash and cash equivalents: 6 of 11 periods available· newest 2010-02-28
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-1.5%

Prior period

USD 519.02 million

2008-03-01 – 2009-02-28
Current period

USD 511.28 million

2009-03-01 – 2010-02-28

Exact inputs and evidence

511280798 − 519022843 = -7742045 USD

519022843 USD · 2008-03-01 – 2009-02-28
Inspect prior input Prior source
511280798 USD · 2009-03-01 – 2010-02-28
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Cellu Tissue Holdings, Inc. · 2010-02-28 Cellu Tissue Holdings, Inc. (edgar:1295976) Year-over-year change in Revenue: -7742045 USD Concept: fundies:Revenue Period: 2009-03-01 to 2010-02-28 Values: Latest reported Published: 2026-11-02T19:43:00Z Snapshot: 089dcbc8ce7cfadb793c3521bfe9108cd9490c4fdd1686f3545376482651099e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1295976?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 511280798 USD (2009-03-01 to 2010-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295976/0001193125-10-101417.txt#5786 Input fundies:Revenue: 519022843 USD (2008-03-01 to 2009-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295976/0001193125-10-101417.txt#5786
The citation records this snapshot. The page link may show a newer release later.
Net income
-42.6%

Prior period

USD 6.56 million

2008-03-01 – 2009-02-28
Current period

USD 3.76 million

2009-03-01 – 2010-02-28

Exact inputs and evidence

3762621 − 6560188 = -2797567 USD

6560188 USD · 2008-03-01 – 2009-02-28
Inspect prior input Prior source
3762621 USD · 2009-03-01 – 2010-02-28
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Cellu Tissue Holdings, Inc. · 2010-02-28 Cellu Tissue Holdings, Inc. (edgar:1295976) Year-over-year change in Net income: -2797567 USD Concept: fundies:NetIncome Period: 2009-03-01 to 2010-02-28 Values: Latest reported Published: 2026-11-02T19:43:00Z Snapshot: 089dcbc8ce7cfadb793c3521bfe9108cd9490c4fdd1686f3545376482651099e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1295976?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 3762621 USD (2009-03-01 to 2010-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295976/0001193125-10-101417.txt#6949 Input fundies:NetIncome: 6560188 USD (2008-03-01 to 2009-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295976/0001193125-10-101417.txt#6949
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+129.4%

Prior period

USD 24.06 million

2008-03-01 – 2009-02-28
Current period

USD 55.19 million

2009-03-01 – 2010-02-28

Exact inputs and evidence

55192165 − 24059843 = 31132322 USD

24059843 USD · 2008-03-01 – 2009-02-28
Inspect prior input Prior source
55192165 USD · 2009-03-01 – 2010-02-28
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Cellu Tissue Holdings, Inc. · 2010-02-28 Cellu Tissue Holdings, Inc. (edgar:1295976) Year-over-year change in Operating cash flow: 31132322 USD Concept: fundies:OperatingCashFlow Period: 2009-03-01 to 2010-02-28 Values: Latest reported Published: 2026-11-02T19:43:00Z Snapshot: 089dcbc8ce7cfadb793c3521bfe9108cd9490c4fdd1686f3545376482651099e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1295976?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 55192165 USD (2009-03-01 to 2010-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295976/0001193125-10-101417.txt#7215 Input fundies:OperatingCashFlow: 24059843 USD (2008-03-01 to 2009-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295976/0001193125-10-101417.txt#7215
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+64.6%

Prior period

USD 16.4 million

2008-03-01 – 2009-02-28
Current period

USD 26.99 million

2009-03-01 – 2010-02-28

Exact inputs and evidence

26993044 − 16401848 = 10591196 USD

16401848 USD · 2008-03-01 – 2009-02-28
Inspect prior input Prior source
26993044 USD · 2009-03-01 – 2010-02-28
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Cellu Tissue Holdings, Inc. · 2010-02-28 Cellu Tissue Holdings, Inc. (edgar:1295976) Year-over-year change in Capital expenditure: 10591196 USD Concept: fundies:CapitalExpenditure Period: 2009-03-01 to 2010-02-28 Values: Latest reported Published: 2026-11-02T19:43:00Z Snapshot: 089dcbc8ce7cfadb793c3521bfe9108cd9490c4fdd1686f3545376482651099e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1295976?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 26993044 USD (2009-03-01 to 2010-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295976/0001193125-10-101417.txt#7257 Input fundies:CapitalExpenditure: 16401848 USD (2008-03-01 to 2009-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295976/0001193125-10-101417.txt#7257
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2010 2009-03-01 – 2010-02-28

Revenue USD 511.28 million 100% of revenue
Operating costs Derived USD 459.1 million 90% of revenue
Operating income USD 52.18 million 10% of revenue
Tax, interest and other Derived USD 48.41 million 9.5% of revenue
Net income USD 3.76 million 0.7% of revenue

Cash

Operating cash flow USD 55.19 million 11% of revenue
Capital expenditure USD 26.99 million 5.3% of revenue
Free cash flow Derived USD 28.2 million 5.5% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2003 92%
2004 93%
2005 93%
2006 Net loss: net income was −0.8% of revenue.
2007 Net loss: net income was −2.6% of revenue.
2008 96%
2009 94%
2010 9.5%90%

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2003 2002-03-01 – 2003-02-28	232437928	214207824 Derived	18230104	2502746 Derived	15727358	5231710 Derived	Source 2002-03-01 – 2003-02-28: 232437928 USD Inspect Revenue Open source 2002-03-01 – 2003-02-28: 18230104 USD Inspect Operating Income Open source 2002-03-01 – 2003-02-28: 15727358 USD Inspect Net Income Open source 2002-03-01 – 2003-02-28: 21311650 USD Inspect Operating Cash Flow Open source 2002-03-01 – 2003-02-28: 16079940 USD Inspect Capital Expenditure Open source
2004 2003-03-01 – 2004-02-29	290262517	270314146 Derived	19948371	12801258 Derived	7147113	9711754 Derived	Source 2003-03-01 – 2004-02-29: 290262517 USD Inspect Revenue Open source 2003-03-01 – 2004-02-29: 19948371 USD Inspect Operating Income Open source 2003-03-01 – 2004-02-29: 7147113 USD Inspect Net Income Open source 2003-03-01 – 2004-02-29: 20258733 USD Inspect Operating Cash Flow Open source 2003-03-01 – 2004-02-29: 10546979 USD Inspect Capital Expenditure Open source
2005 2004-03-01 – 2005-02-28	332893044	310938104 Derived	21954940	18858945 Derived	3095995	20816027 Derived	Source 2004-03-01 – 2005-02-28: 332893044 USD Inspect Revenue Open source 2004-03-01 – 2005-02-28: 21954940 USD Inspect Operating Income Open source 2004-03-01 – 2005-02-28: 3095995 USD Inspect Net Income Open source 2004-03-01 – 2005-02-28: 32235265 USD Inspect Operating Cash Flow Open source 2004-03-01 – 2005-02-28: 11419238 USD Inspect Capital Expenditure Open source
2006 2005-03-01 – 2006-02-28	328832864	317399823 Derived	11433041	14002395 Derived	-2569354	-4450400 Derived	Source 2005-03-01 – 2006-02-28: 328832864 USD Inspect Revenue Open source 2005-03-01 – 2006-02-28: 11433041 USD Inspect Operating Income Open source 2005-03-01 – 2006-02-28: -2569354 USD Inspect Net Income Open source 2005-03-01 – 2006-02-28: 8599766 USD Inspect Operating Cash Flow Open source 2005-03-01 – 2006-02-28: 13050166 USD Inspect Capital Expenditure Open source
2007 2006-03-01 – 2007-02-28	241236592	240221722 Derived	1014870	7207236 Derived	-6192366	2462310 Derived	Source 2006-03-01 – 2007-02-28: 241236592 USD Inspect Revenue Open source 2006-03-01 – 2007-02-28: 1014870 USD Inspect Operating Income Open source 2006-03-01 – 2007-02-28: -6192366 USD Inspect Net Income Open source 2006-03-01 – 2007-02-28: 10139451 USD Inspect Operating Cash Flow Open source 2006-03-01 – 2007-02-28: 7677141 USD Inspect Capital Expenditure Open source
2008 2007-03-01 – 2008-02-29	443081130	423451047 Derived	19630083	15928327 Derived	3701756	-681547 Derived	Source 2007-03-01 – 2008-02-29: 443081130 USD Inspect Revenue Open source 2007-03-01 – 2008-02-29: 19630083 USD Inspect Operating Income Open source 2007-03-01 – 2008-02-29: 3701756 USD Inspect Net Income Open source 2007-03-01 – 2008-02-29: 19795879 USD Inspect Operating Cash Flow Open source 2007-03-01 – 2008-02-29: 20477426 USD Inspect Capital Expenditure Open source
2009 2008-03-01 – 2009-02-28	519022843	488859578 Derived	30163265	23603077 Derived	6560188	7657995 Derived	Source 2008-03-01 – 2009-02-28: 519022843 USD Inspect Revenue Open source 2008-03-01 – 2009-02-28: 30163265 USD Inspect Operating Income Open source 2008-03-01 – 2009-02-28: 6560188 USD Inspect Net Income Open source 2008-03-01 – 2009-02-28: 24059843 USD Inspect Operating Cash Flow Open source 2008-03-01 – 2009-02-28: 16401848 USD Inspect Capital Expenditure Open source
2010 2009-03-01 – 2010-02-28	511280798	459104845 Derived	52175953	48413332 Derived	3762621	28199121 Derived	Source 2009-03-01 – 2010-02-28: 511280798 USD Inspect Revenue Open source 2009-03-01 – 2010-02-28: 52175953 USD Inspect Operating Income Open source 2009-03-01 – 2010-02-28: 3762621 USD Inspect Net Income Open source 2009-03-01 – 2010-02-28: 55192165 USD Inspect Operating Cash Flow Open source 2009-03-01 – 2010-02-28: 26993044 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 511.3M 2010

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20032003-02-28	Revenue	232437928	Revenue: 232437928 Open source
20042004-02-29	Revenue	290262517	Revenue: 290262517 Open source
20052005-02-28	Revenue	332893044	Revenue: 332893044 Open source
20062006-02-28	Revenue	328832864	Revenue: 328832864 Open source
20072007-02-28	Revenue	241236592	Revenue: 241236592 Open source
20082008-02-29	Revenue	443081130	Revenue: 443081130 Open source
20092009-02-28	Revenue	519022843	Revenue: 519022843 Open source
20102010-02-28	Revenue	511280798	Revenue: 511280798 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-1.5% 2010

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20032003-02-28	Year over year	No prior comparable period	Revenue: 232437928 Open source
20042004-02-29	Year over year	24.9%	Revenue: 290262517 Open source Revenue: 232437928 Open source
20052005-02-28	Year over year	14.7%	Revenue: 332893044 Open source Revenue: 290262517 Open source
20062006-02-28	Year over year	-1.2%	Revenue: 328832864 Open source Revenue: 332893044 Open source
20072007-02-28	Year over year	-26.6%	Revenue: 241236592 Open source Revenue: 328832864 Open source
20082008-02-29	Year over year	83.7%	Revenue: 443081130 Open source Revenue: 241236592 Open source
20092009-02-28	Year over year	17.1%	Revenue: 519022843 Open source Revenue: 443081130 Open source
20102010-02-28	Year over year	-1.5%	Revenue: 511280798 Open source Revenue: 519022843 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 10.2% 2010

Net margin 0.7% 2010

Free cash flow margin 5.5% 2010

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20032003-02-28	Operating margin	7.8%	Operating Income: 18230104 Open source Revenue: 232437928 Open source
20042004-02-29	Operating margin	6.9%	Operating Income: 19948371 Open source Revenue: 290262517 Open source
20052005-02-28	Operating margin	6.6%	Operating Income: 21954940 Open source Revenue: 332893044 Open source
20062006-02-28	Operating margin	3.5%	Operating Income: 11433041 Open source Revenue: 328832864 Open source
20072007-02-28	Operating margin	0.4%	Operating Income: 1014870 Open source Revenue: 241236592 Open source
20082008-02-29	Operating margin	4.4%	Operating Income: 19630083 Open source Revenue: 443081130 Open source
20092009-02-28	Operating margin	5.8%	Operating Income: 30163265 Open source Revenue: 519022843 Open source
20102010-02-28	Operating margin	10.2%	Operating Income: 52175953 Open source Revenue: 511280798 Open source
20032003-02-28	Net margin	6.8%	Net Income: 15727358 Open source Revenue: 232437928 Open source
20042004-02-29	Net margin	2.5%	Net Income: 7147113 Open source Revenue: 290262517 Open source
20052005-02-28	Net margin	0.9%	Net Income: 3095995 Open source Revenue: 332893044 Open source
20062006-02-28	Net margin	-0.8%	Net Income: -2569354 Open source Revenue: 328832864 Open source
20072007-02-28	Net margin	-2.6%	Net Income: -6192366 Open source Revenue: 241236592 Open source
20082008-02-29	Net margin	0.8%	Net Income: 3701756 Open source Revenue: 443081130 Open source
20092009-02-28	Net margin	1.3%	Net Income: 6560188 Open source Revenue: 519022843 Open source
20102010-02-28	Net margin	0.7%	Net Income: 3762621 Open source Revenue: 511280798 Open source
20032003-02-28	Free cash flow margin	2.3%	Revenue: 232437928 Open source Operating Cash Flow: 21311650 Open source Capital Expenditure: 16079940 Open source
20042004-02-29	Free cash flow margin	3.3%	Revenue: 290262517 Open source Operating Cash Flow: 20258733 Open source Capital Expenditure: 10546979 Open source
20052005-02-28	Free cash flow margin	6.3%	Revenue: 332893044 Open source Operating Cash Flow: 32235265 Open source Capital Expenditure: 11419238 Open source
20062006-02-28	Free cash flow margin	-1.4%	Revenue: 328832864 Open source Operating Cash Flow: 8599766 Open source Capital Expenditure: 13050166 Open source
20072007-02-28	Free cash flow margin	1%	Revenue: 241236592 Open source Operating Cash Flow: 10139451 Open source Capital Expenditure: 7677141 Open source
20082008-02-29	Free cash flow margin	-0.2%	Revenue: 443081130 Open source Operating Cash Flow: 19795879 Open source Capital Expenditure: 20477426 Open source
20092009-02-28	Free cash flow margin	1.5%	Revenue: 519022843 Open source Operating Cash Flow: 24059843 Open source Capital Expenditure: 16401848 Open source
20102010-02-28	Free cash flow margin	5.5%	Revenue: 511280798 Open source Operating Cash Flow: 55192165 Open source Capital Expenditure: 26993044 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 55.2M 2010

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20032003-02-28	Operating cash flow	21311650	Operating Cash Flow: 21311650 Open source
20042004-02-29	Operating cash flow	20258733	Operating Cash Flow: 20258733 Open source
20052005-02-28	Operating cash flow	32235265	Operating Cash Flow: 32235265 Open source
20062006-02-28	Operating cash flow	8599766	Operating Cash Flow: 8599766 Open source
20072007-02-28	Operating cash flow	10139451	Operating Cash Flow: 10139451 Open source
20082008-02-29	Operating cash flow	19795879	Operating Cash Flow: 19795879 Open source
20092009-02-28	Operating cash flow	24059843	Operating Cash Flow: 24059843 Open source
20102010-02-28	Operating cash flow	55192165	Operating Cash Flow: 55192165 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 28.2M 2010

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20032003-02-28	Free cash flow	5231710	Operating Cash Flow: 21311650 Open source Capital Expenditure: 16079940 Open source
20042004-02-29	Free cash flow	9711754	Operating Cash Flow: 20258733 Open source Capital Expenditure: 10546979 Open source
20052005-02-28	Free cash flow	20816027	Operating Cash Flow: 32235265 Open source Capital Expenditure: 11419238 Open source
20062006-02-28	Free cash flow	-4450400	Operating Cash Flow: 8599766 Open source Capital Expenditure: 13050166 Open source
20072007-02-28	Free cash flow	2462310	Operating Cash Flow: 10139451 Open source Capital Expenditure: 7677141 Open source
20082008-02-29	Free cash flow	-681547	Operating Cash Flow: 19795879 Open source Capital Expenditure: 20477426 Open source
20092009-02-28	Free cash flow	7657995	Operating Cash Flow: 24059843 Open source Capital Expenditure: 16401848 Open source
20102010-02-28	Free cash flow	28199121	Operating Cash Flow: 55192165 Open source Capital Expenditure: 26993044 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2003-02-28	Liabilities / assets	Not reported	No source recorded
2004-02-29	Liabilities / assets	Not reported	Total Assets: 186942713 Open source
2005-02-28	Liabilities / assets	Not reported	Total Assets: 210843077 Open source
2006-02-28	Liabilities / assets	Not reported	Total Assets: 210232114 Open source
2007-02-28	Liabilities / assets	Not reported	Total Assets: 345343091 Open source
2008-02-29	Liabilities / assets	Not reported	Total Assets: 423216679 Open source
2009-02-28	Liabilities / assets	Not reported	Total Assets: 484046800 Open source
2010-02-28	Liabilities / assets	Not reported	Total Assets: 502706386 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.65× 2010

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2003-02-28	Current assets / current liabilities	Not reported	No source recorded
20042004-02-29	Current assets / current liabilities	1.32×	Current Assets: 68207529 Open source Current Liabilities: 51690509 Open source
20052005-02-28	Current assets / current liabilities	2.19×	Current Assets: 92446614 Open source Current Liabilities: 42122423 Open source
20062006-02-28	Current assets / current liabilities	2.19×	Current Assets: 92470055 Open source Current Liabilities: 42175324 Open source
20072007-02-28	Current assets / current liabilities	2.24×	Current Assets: 89772095 Open source Current Liabilities: 40048997 Open source
20082008-02-29	Current assets / current liabilities	1.18×	Current Assets: 90711682 Open source Current Liabilities: 76955609 Open source
20092009-02-28	Current assets / current liabilities	1.15×	Current Assets: 107418136 Open source Current Liabilities: 93459857 Open source
20102010-02-28	Current assets / current liabilities	1.65×	Current Assets: 117325397 Open source Current Liabilities: 71201399 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2003 2002-03-01 – 2003-02-28	USD 15.73 million Exact value Exact value: 15727358 USD 2002-03-01 – 2003-02-28: 15727358 USD Inspect Net Income Open source Share or cite Citation for Net Income · Cellu Tissue Holdings, Inc. · 2003-02-28 Cellu Tissue Holdings, Inc. (edgar:1295976) Net Income: 15727358 USD Concept: fundies:NetIncome Period: 2002-03-01 to 2003-02-28 Values: Latest reported Published: 2026-11-02T19:43:00Z Snapshot: 089dcbc8ce7cfadb793c3521bfe9108cd9490c4fdd1686f3545376482651099e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1295976/explain?concept=fundies%3ANetIncome&period=2003-02-28&surface=latest&period_type=duration&start=2002-03-01&unit=USD&dimensions= Input fundies:NetIncome: 15727358 USD (2002-03-01 to 2003-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295976/0001047469-05-015748.txt#6376 The citation records this snapshot. The page link may show a newer release later.	USD 21.31 million Exact value Exact value: 21311650 USD 2002-03-01 – 2003-02-28: 21311650 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Cellu Tissue Holdings, Inc. · 2003-02-28 Cellu Tissue Holdings, Inc. (edgar:1295976) Operating Cash Flow: 21311650 USD Concept: fundies:OperatingCashFlow Period: 2002-03-01 to 2003-02-28 Values: Latest reported Published: 2026-11-02T19:43:00Z Snapshot: 089dcbc8ce7cfadb793c3521bfe9108cd9490c4fdd1686f3545376482651099e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1295976/explain?concept=fundies%3AOperatingCashFlow&period=2003-02-28&surface=latest&period_type=duration&start=2002-03-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 21311650 USD (2002-03-01 to 2003-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295976/0001047469-05-015748.txt#6680 The citation records this snapshot. The page link may show a newer release later.	USD 16.08 million Exact value Exact value: 16079940 USD 2002-03-01 – 2003-02-28: 16079940 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Cellu Tissue Holdings, Inc. · 2003-02-28 Cellu Tissue Holdings, Inc. (edgar:1295976) Capital Expenditure: 16079940 USD Concept: fundies:CapitalExpenditure Period: 2002-03-01 to 2003-02-28 Values: Latest reported Published: 2026-11-02T19:43:00Z Snapshot: 089dcbc8ce7cfadb793c3521bfe9108cd9490c4fdd1686f3545376482651099e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1295976/explain?concept=fundies%3ACapitalExpenditure&period=2003-02-28&surface=latest&period_type=duration&start=2002-03-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 16079940 USD (2002-03-01 to 2003-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295976/0001047469-05-015748.txt#6719 The citation records this snapshot. The page link may show a newer release later.	USD 5.23 million Calculation and evidence 21311650 − 16079940 USD Exact free cash flow: 5231710 USD 2002-03-01 – 2003-02-28: 21311650 USD · Inspect Operating Cash Flow · Source 2002-03-01 – 2003-02-28: 16079940 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Cellu Tissue Holdings, Inc. · 2003-02-28 Cellu Tissue Holdings, Inc. (edgar:1295976) Free cash flow: 5231710 USD Concept: free-cash-flow Period: 2002-03-01 to 2003-02-28 Values: Latest reported Published: 2026-11-02T19:43:00Z Snapshot: 089dcbc8ce7cfadb793c3521bfe9108cd9490c4fdd1686f3545376482651099e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1295976?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 21311650 USD (2002-03-01 to 2003-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295976/0001047469-05-015748.txt#6680 Input fundies:CapitalExpenditure: 16079940 USD (2002-03-01 to 2003-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295976/0001047469-05-015748.txt#6719 The citation records this snapshot. The page link may show a newer release later.
2004 2003-03-01 – 2004-02-29	USD 7.15 million Exact value Exact value: 7147113 USD 2003-03-01 – 2004-02-29: 7147113 USD Inspect Net Income Open source Share or cite Citation for Net Income · Cellu Tissue Holdings, Inc. · 2004-02-29 Cellu Tissue Holdings, Inc. (edgar:1295976) Net Income: 7147113 USD Concept: fundies:NetIncome Period: 2003-03-01 to 2004-02-29 Values: Latest reported Published: 2026-11-02T19:43:00Z Snapshot: 089dcbc8ce7cfadb793c3521bfe9108cd9490c4fdd1686f3545376482651099e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1295976/explain?concept=fundies%3ANetIncome&period=2004-02-29&surface=latest&period_type=duration&start=2003-03-01&unit=USD&dimensions= Input fundies:NetIncome: 7147113 USD (2003-03-01 to 2004-02-29) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295976/0001047469-06-006713.txt#6440 The citation records this snapshot. The page link may show a newer release later.	USD 20.26 million Exact value Exact value: 20258733 USD 2003-03-01 – 2004-02-29: 20258733 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Cellu Tissue Holdings, Inc. · 2004-02-29 Cellu Tissue Holdings, Inc. (edgar:1295976) Operating Cash Flow: 20258733 USD Concept: fundies:OperatingCashFlow Period: 2003-03-01 to 2004-02-29 Values: Latest reported Published: 2026-11-02T19:43:00Z Snapshot: 089dcbc8ce7cfadb793c3521bfe9108cd9490c4fdd1686f3545376482651099e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1295976/explain?concept=fundies%3AOperatingCashFlow&period=2004-02-29&surface=latest&period_type=duration&start=2003-03-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 20258733 USD (2003-03-01 to 2004-02-29) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295976/0001047469-06-006713.txt#6715 The citation records this snapshot. The page link may show a newer release later.	USD 10.55 million Exact value Exact value: 10546979 USD 2003-03-01 – 2004-02-29: 10546979 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Cellu Tissue Holdings, Inc. · 2004-02-29 Cellu Tissue Holdings, Inc. (edgar:1295976) Capital Expenditure: 10546979 USD Concept: fundies:CapitalExpenditure Period: 2003-03-01 to 2004-02-29 Values: Latest reported Published: 2026-11-02T19:43:00Z Snapshot: 089dcbc8ce7cfadb793c3521bfe9108cd9490c4fdd1686f3545376482651099e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1295976/explain?concept=fundies%3ACapitalExpenditure&period=2004-02-29&surface=latest&period_type=duration&start=2003-03-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 10546979 USD (2003-03-01 to 2004-02-29) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295976/0001047469-06-006713.txt#6757 The citation records this snapshot. The page link may show a newer release later.	USD 9.71 million Calculation and evidence 20258733 − 10546979 USD Exact free cash flow: 9711754 USD 2003-03-01 – 2004-02-29: 20258733 USD · Inspect Operating Cash Flow · Source 2003-03-01 – 2004-02-29: 10546979 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Cellu Tissue Holdings, Inc. · 2004-02-29 Cellu Tissue Holdings, Inc. (edgar:1295976) Free cash flow: 9711754 USD Concept: free-cash-flow Period: 2003-03-01 to 2004-02-29 Values: Latest reported Published: 2026-11-02T19:43:00Z Snapshot: 089dcbc8ce7cfadb793c3521bfe9108cd9490c4fdd1686f3545376482651099e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1295976?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 20258733 USD (2003-03-01 to 2004-02-29) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295976/0001047469-06-006713.txt#6715 Input fundies:CapitalExpenditure: 10546979 USD (2003-03-01 to 2004-02-29) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295976/0001047469-06-006713.txt#6757 The citation records this snapshot. The page link may show a newer release later.
2005 2004-03-01 – 2005-02-28	USD 3.1 million Exact value Exact value: 3095995 USD 2004-03-01 – 2005-02-28: 3095995 USD Inspect Net Income Open source Share or cite Citation for Net Income · Cellu Tissue Holdings, Inc. · 2005-02-28 Cellu Tissue Holdings, Inc. (edgar:1295976) Net Income: 3095995 USD Concept: fundies:NetIncome Period: 2004-03-01 to 2005-02-28 Values: Latest reported Published: 2026-11-02T19:43:00Z Snapshot: 089dcbc8ce7cfadb793c3521bfe9108cd9490c4fdd1686f3545376482651099e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1295976/explain?concept=fundies%3ANetIncome&period=2005-02-28&surface=latest&period_type=duration&start=2004-03-01&unit=USD&dimensions= Input fundies:NetIncome: 3095995 USD (2004-03-01 to 2005-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295976/0001047469-06-006713.txt#6440 The citation records this snapshot. The page link may show a newer release later.	USD 32.24 million Exact value Exact value: 32235265 USD 2004-03-01 – 2005-02-28: 32235265 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Cellu Tissue Holdings, Inc. · 2005-02-28 Cellu Tissue Holdings, Inc. (edgar:1295976) Operating Cash Flow: 32235265 USD Concept: fundies:OperatingCashFlow Period: 2004-03-01 to 2005-02-28 Values: Latest reported Published: 2026-11-02T19:43:00Z Snapshot: 089dcbc8ce7cfadb793c3521bfe9108cd9490c4fdd1686f3545376482651099e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1295976/explain?concept=fundies%3AOperatingCashFlow&period=2005-02-28&surface=latest&period_type=duration&start=2004-03-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 32235265 USD (2004-03-01 to 2005-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295976/0001047469-06-006713.txt#6715 The citation records this snapshot. The page link may show a newer release later.	USD 11.42 million Exact value Exact value: 11419238 USD 2004-03-01 – 2005-02-28: 11419238 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Cellu Tissue Holdings, Inc. · 2005-02-28 Cellu Tissue Holdings, Inc. (edgar:1295976) Capital Expenditure: 11419238 USD Concept: fundies:CapitalExpenditure Period: 2004-03-01 to 2005-02-28 Values: Latest reported Published: 2026-11-02T19:43:00Z Snapshot: 089dcbc8ce7cfadb793c3521bfe9108cd9490c4fdd1686f3545376482651099e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1295976/explain?concept=fundies%3ACapitalExpenditure&period=2005-02-28&surface=latest&period_type=duration&start=2004-03-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 11419238 USD (2004-03-01 to 2005-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295976/0001047469-06-006713.txt#6757 The citation records this snapshot. The page link may show a newer release later.	USD 20.82 million Calculation and evidence 32235265 − 11419238 USD Exact free cash flow: 20816027 USD 2004-03-01 – 2005-02-28: 32235265 USD · Inspect Operating Cash Flow · Source 2004-03-01 – 2005-02-28: 11419238 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Cellu Tissue Holdings, Inc. · 2005-02-28 Cellu Tissue Holdings, Inc. (edgar:1295976) Free cash flow: 20816027 USD Concept: free-cash-flow Period: 2004-03-01 to 2005-02-28 Values: Latest reported Published: 2026-11-02T19:43:00Z Snapshot: 089dcbc8ce7cfadb793c3521bfe9108cd9490c4fdd1686f3545376482651099e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1295976?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 32235265 USD (2004-03-01 to 2005-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295976/0001047469-06-006713.txt#6715 Input fundies:CapitalExpenditure: 11419238 USD (2004-03-01 to 2005-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295976/0001047469-06-006713.txt#6757 The citation records this snapshot. The page link may show a newer release later.
2006 2005-03-01 – 2006-02-28	−USD 2.57 million Exact value Exact value: -2569354 USD 2005-03-01 – 2006-02-28: -2569354 USD Inspect Net Income Open source Share or cite Citation for Net Income · Cellu Tissue Holdings, Inc. · 2006-02-28 Cellu Tissue Holdings, Inc. (edgar:1295976) Net Income: -2569354 USD Concept: fundies:NetIncome Period: 2005-03-01 to 2006-02-28 Values: Latest reported Published: 2026-11-02T19:43:00Z Snapshot: 089dcbc8ce7cfadb793c3521bfe9108cd9490c4fdd1686f3545376482651099e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1295976/explain?concept=fundies%3ANetIncome&period=2006-02-28&surface=latest&period_type=duration&start=2005-03-01&unit=USD&dimensions= Input fundies:NetIncome: -2569354 USD (2005-03-01 to 2006-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295976/0001047469-06-006713.txt#6440 The citation records this snapshot. The page link may show a newer release later.	USD 8.6 million Exact value Exact value: 8599766 USD 2005-03-01 – 2006-02-28: 8599766 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Cellu Tissue Holdings, Inc. · 2006-02-28 Cellu Tissue Holdings, Inc. (edgar:1295976) Operating Cash Flow: 8599766 USD Concept: fundies:OperatingCashFlow Period: 2005-03-01 to 2006-02-28 Values: Latest reported Published: 2026-11-02T19:43:00Z Snapshot: 089dcbc8ce7cfadb793c3521bfe9108cd9490c4fdd1686f3545376482651099e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1295976/explain?concept=fundies%3AOperatingCashFlow&period=2006-02-28&surface=latest&period_type=duration&start=2005-03-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 8599766 USD (2005-03-01 to 2006-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295976/0001047469-06-006713.txt#6715 The citation records this snapshot. The page link may show a newer release later.	USD 13.05 million Exact value Exact value: 13050166 USD 2005-03-01 – 2006-02-28: 13050166 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Cellu Tissue Holdings, Inc. · 2006-02-28 Cellu Tissue Holdings, Inc. (edgar:1295976) Capital Expenditure: 13050166 USD Concept: fundies:CapitalExpenditure Period: 2005-03-01 to 2006-02-28 Values: Latest reported Published: 2026-11-02T19:43:00Z Snapshot: 089dcbc8ce7cfadb793c3521bfe9108cd9490c4fdd1686f3545376482651099e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1295976/explain?concept=fundies%3ACapitalExpenditure&period=2006-02-28&surface=latest&period_type=duration&start=2005-03-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 13050166 USD (2005-03-01 to 2006-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295976/0001047469-06-006713.txt#6757 The citation records this snapshot. The page link may show a newer release later.	−USD 4.45 million Calculation and evidence 8599766 − 13050166 USD Exact free cash flow: -4450400 USD 2005-03-01 – 2006-02-28: 8599766 USD · Inspect Operating Cash Flow · Source 2005-03-01 – 2006-02-28: 13050166 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Cellu Tissue Holdings, Inc. · 2006-02-28 Cellu Tissue Holdings, Inc. (edgar:1295976) Free cash flow: -4450400 USD Concept: free-cash-flow Period: 2005-03-01 to 2006-02-28 Values: Latest reported Published: 2026-11-02T19:43:00Z Snapshot: 089dcbc8ce7cfadb793c3521bfe9108cd9490c4fdd1686f3545376482651099e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1295976?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 8599766 USD (2005-03-01 to 2006-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295976/0001047469-06-006713.txt#6715 Input fundies:CapitalExpenditure: 13050166 USD (2005-03-01 to 2006-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295976/0001047469-06-006713.txt#6757 The citation records this snapshot. The page link may show a newer release later.
2007 2006-03-01 – 2007-02-28	−USD 6.19 million Exact value Exact value: -6192366 USD 2006-03-01 – 2007-02-28: -6192366 USD Inspect Net Income Open source Share or cite Citation for Net Income · Cellu Tissue Holdings, Inc. · 2007-02-28 Cellu Tissue Holdings, Inc. (edgar:1295976) Net Income: -6192366 USD Concept: fundies:NetIncome Period: 2006-03-01 to 2007-02-28 Values: Latest reported Published: 2026-11-02T19:43:00Z Snapshot: 089dcbc8ce7cfadb793c3521bfe9108cd9490c4fdd1686f3545376482651099e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1295976/explain?concept=fundies%3ANetIncome&period=2007-02-28&surface=latest&period_type=duration&start=2006-03-01&unit=USD&dimensions= Input fundies:NetIncome: -6192366 USD (2006-03-01 to 2007-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295976/0001104659-07-041415.txt#17673 The citation records this snapshot. The page link may show a newer release later.	USD 10.14 million Exact value Exact value: 10139451 USD 2006-03-01 – 2007-02-28: 10139451 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Cellu Tissue Holdings, Inc. · 2007-02-28 Cellu Tissue Holdings, Inc. (edgar:1295976) Operating Cash Flow: 10139451 USD Concept: fundies:OperatingCashFlow Period: 2006-03-01 to 2007-02-28 Values: Latest reported Published: 2026-11-02T19:43:00Z Snapshot: 089dcbc8ce7cfadb793c3521bfe9108cd9490c4fdd1686f3545376482651099e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1295976/explain?concept=fundies%3AOperatingCashFlow&period=2007-02-28&surface=latest&period_type=duration&start=2006-03-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 10139451 USD (2006-03-01 to 2007-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295976/0001104659-07-041415.txt#18298 The citation records this snapshot. The page link may show a newer release later.	USD 7.68 million Exact value Exact value: 7677141 USD 2006-03-01 – 2007-02-28: 7677141 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Cellu Tissue Holdings, Inc. · 2007-02-28 Cellu Tissue Holdings, Inc. (edgar:1295976) Capital Expenditure: 7677141 USD Concept: fundies:CapitalExpenditure Period: 2006-03-01 to 2007-02-28 Values: Latest reported Published: 2026-11-02T19:43:00Z Snapshot: 089dcbc8ce7cfadb793c3521bfe9108cd9490c4fdd1686f3545376482651099e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1295976/explain?concept=fundies%3ACapitalExpenditure&period=2007-02-28&surface=latest&period_type=duration&start=2006-03-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 7677141 USD (2006-03-01 to 2007-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295976/0001104659-07-041415.txt#18537 The citation records this snapshot. The page link may show a newer release later.	USD 2.46 million Calculation and evidence 10139451 − 7677141 USD Exact free cash flow: 2462310 USD 2006-03-01 – 2007-02-28: 10139451 USD · Inspect Operating Cash Flow · Source 2006-03-01 – 2007-02-28: 7677141 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Cellu Tissue Holdings, Inc. · 2007-02-28 Cellu Tissue Holdings, Inc. (edgar:1295976) Free cash flow: 2462310 USD Concept: free-cash-flow Period: 2006-03-01 to 2007-02-28 Values: Latest reported Published: 2026-11-02T19:43:00Z Snapshot: 089dcbc8ce7cfadb793c3521bfe9108cd9490c4fdd1686f3545376482651099e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1295976?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 10139451 USD (2006-03-01 to 2007-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295976/0001104659-07-041415.txt#18298 Input fundies:CapitalExpenditure: 7677141 USD (2006-03-01 to 2007-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295976/0001104659-07-041415.txt#18537 The citation records this snapshot. The page link may show a newer release later.
2008 2007-03-01 – 2008-02-29	USD 3.7 million Exact value Exact value: 3701756 USD 2007-03-01 – 2008-02-29: 3701756 USD Inspect Net Income Open source Share or cite Citation for Net Income · Cellu Tissue Holdings, Inc. · 2008-02-29 Cellu Tissue Holdings, Inc. (edgar:1295976) Net Income: 3701756 USD Concept: fundies:NetIncome Period: 2007-03-01 to 2008-02-29 Values: Latest reported Published: 2026-11-02T19:43:00Z Snapshot: 089dcbc8ce7cfadb793c3521bfe9108cd9490c4fdd1686f3545376482651099e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1295976/explain?concept=fundies%3ANetIncome&period=2008-02-29&surface=latest&period_type=duration&start=2007-03-01&unit=USD&dimensions= Input fundies:NetIncome: 3701756 USD (2007-03-01 to 2008-02-29) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295976/0001193125-10-101417.txt#6949 The citation records this snapshot. The page link may show a newer release later.	USD 19.8 million Exact value Exact value: 19795879 USD 2007-03-01 – 2008-02-29: 19795879 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Cellu Tissue Holdings, Inc. · 2008-02-29 Cellu Tissue Holdings, Inc. (edgar:1295976) Operating Cash Flow: 19795879 USD Concept: fundies:OperatingCashFlow Period: 2007-03-01 to 2008-02-29 Values: Latest reported Published: 2026-11-02T19:43:00Z Snapshot: 089dcbc8ce7cfadb793c3521bfe9108cd9490c4fdd1686f3545376482651099e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1295976/explain?concept=fundies%3AOperatingCashFlow&period=2008-02-29&surface=latest&period_type=duration&start=2007-03-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 19795879 USD (2007-03-01 to 2008-02-29) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295976/0001193125-10-101417.txt#7215 The citation records this snapshot. The page link may show a newer release later.	USD 20.48 million Exact value Exact value: 20477426 USD 2007-03-01 – 2008-02-29: 20477426 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Cellu Tissue Holdings, Inc. · 2008-02-29 Cellu Tissue Holdings, Inc. (edgar:1295976) Capital Expenditure: 20477426 USD Concept: fundies:CapitalExpenditure Period: 2007-03-01 to 2008-02-29 Values: Latest reported Published: 2026-11-02T19:43:00Z Snapshot: 089dcbc8ce7cfadb793c3521bfe9108cd9490c4fdd1686f3545376482651099e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1295976/explain?concept=fundies%3ACapitalExpenditure&period=2008-02-29&surface=latest&period_type=duration&start=2007-03-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 20477426 USD (2007-03-01 to 2008-02-29) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295976/0001193125-10-101417.txt#7257 The citation records this snapshot. The page link may show a newer release later.	−USD 681,547 Calculation and evidence 19795879 − 20477426 USD Exact free cash flow: -681547 USD 2007-03-01 – 2008-02-29: 19795879 USD · Inspect Operating Cash Flow · Source 2007-03-01 – 2008-02-29: 20477426 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Cellu Tissue Holdings, Inc. · 2008-02-29 Cellu Tissue Holdings, Inc. (edgar:1295976) Free cash flow: -681547 USD Concept: free-cash-flow Period: 2007-03-01 to 2008-02-29 Values: Latest reported Published: 2026-11-02T19:43:00Z Snapshot: 089dcbc8ce7cfadb793c3521bfe9108cd9490c4fdd1686f3545376482651099e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1295976?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 19795879 USD (2007-03-01 to 2008-02-29) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295976/0001193125-10-101417.txt#7215 Input fundies:CapitalExpenditure: 20477426 USD (2007-03-01 to 2008-02-29) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295976/0001193125-10-101417.txt#7257 The citation records this snapshot. The page link may show a newer release later.
2009 2008-03-01 – 2009-02-28	USD 6.56 million Exact value Exact value: 6560188 USD 2008-03-01 – 2009-02-28: 6560188 USD Inspect Net Income Open source Share or cite Citation for Net Income · Cellu Tissue Holdings, Inc. · 2009-02-28 Cellu Tissue Holdings, Inc. (edgar:1295976) Net Income: 6560188 USD Concept: fundies:NetIncome Period: 2008-03-01 to 2009-02-28 Values: Latest reported Published: 2026-11-02T19:43:00Z Snapshot: 089dcbc8ce7cfadb793c3521bfe9108cd9490c4fdd1686f3545376482651099e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1295976/explain?concept=fundies%3ANetIncome&period=2009-02-28&surface=latest&period_type=duration&start=2008-03-01&unit=USD&dimensions= Input fundies:NetIncome: 6560188 USD (2008-03-01 to 2009-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295976/0001193125-10-101417.txt#6949 The citation records this snapshot. The page link may show a newer release later.	USD 24.06 million Exact value Exact value: 24059843 USD 2008-03-01 – 2009-02-28: 24059843 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Cellu Tissue Holdings, Inc. · 2009-02-28 Cellu Tissue Holdings, Inc. (edgar:1295976) Operating Cash Flow: 24059843 USD Concept: fundies:OperatingCashFlow Period: 2008-03-01 to 2009-02-28 Values: Latest reported Published: 2026-11-02T19:43:00Z Snapshot: 089dcbc8ce7cfadb793c3521bfe9108cd9490c4fdd1686f3545376482651099e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1295976/explain?concept=fundies%3AOperatingCashFlow&period=2009-02-28&surface=latest&period_type=duration&start=2008-03-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 24059843 USD (2008-03-01 to 2009-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295976/0001193125-10-101417.txt#7215 The citation records this snapshot. The page link may show a newer release later.	USD 16.4 million Exact value Exact value: 16401848 USD 2008-03-01 – 2009-02-28: 16401848 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Cellu Tissue Holdings, Inc. · 2009-02-28 Cellu Tissue Holdings, Inc. (edgar:1295976) Capital Expenditure: 16401848 USD Concept: fundies:CapitalExpenditure Period: 2008-03-01 to 2009-02-28 Values: Latest reported Published: 2026-11-02T19:43:00Z Snapshot: 089dcbc8ce7cfadb793c3521bfe9108cd9490c4fdd1686f3545376482651099e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1295976/explain?concept=fundies%3ACapitalExpenditure&period=2009-02-28&surface=latest&period_type=duration&start=2008-03-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 16401848 USD (2008-03-01 to 2009-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295976/0001193125-10-101417.txt#7257 The citation records this snapshot. The page link may show a newer release later.	USD 7.66 million Calculation and evidence 24059843 − 16401848 USD Exact free cash flow: 7657995 USD 2008-03-01 – 2009-02-28: 24059843 USD · Inspect Operating Cash Flow · Source 2008-03-01 – 2009-02-28: 16401848 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Cellu Tissue Holdings, Inc. · 2009-02-28 Cellu Tissue Holdings, Inc. (edgar:1295976) Free cash flow: 7657995 USD Concept: free-cash-flow Period: 2008-03-01 to 2009-02-28 Values: Latest reported Published: 2026-11-02T19:43:00Z Snapshot: 089dcbc8ce7cfadb793c3521bfe9108cd9490c4fdd1686f3545376482651099e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1295976?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 24059843 USD (2008-03-01 to 2009-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295976/0001193125-10-101417.txt#7215 Input fundies:CapitalExpenditure: 16401848 USD (2008-03-01 to 2009-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295976/0001193125-10-101417.txt#7257 The citation records this snapshot. The page link may show a newer release later.
2010 2009-03-01 – 2010-02-28	USD 3.76 million Exact value Exact value: 3762621 USD 2009-03-01 – 2010-02-28: 3762621 USD Inspect Net Income Open source Share or cite Citation for Net Income · Cellu Tissue Holdings, Inc. · 2010-02-28 Cellu Tissue Holdings, Inc. (edgar:1295976) Net Income: 3762621 USD Concept: fundies:NetIncome Period: 2009-03-01 to 2010-02-28 Values: Latest reported Published: 2026-11-02T19:43:00Z Snapshot: 089dcbc8ce7cfadb793c3521bfe9108cd9490c4fdd1686f3545376482651099e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1295976/explain?concept=fundies%3ANetIncome&period=2010-02-28&surface=latest&period_type=duration&start=2009-03-01&unit=USD&dimensions= Input fundies:NetIncome: 3762621 USD (2009-03-01 to 2010-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295976/0001193125-10-101417.txt#6949 The citation records this snapshot. The page link may show a newer release later.	USD 55.19 million Exact value Exact value: 55192165 USD 2009-03-01 – 2010-02-28: 55192165 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Cellu Tissue Holdings, Inc. · 2010-02-28 Cellu Tissue Holdings, Inc. (edgar:1295976) Operating Cash Flow: 55192165 USD Concept: fundies:OperatingCashFlow Period: 2009-03-01 to 2010-02-28 Values: Latest reported Published: 2026-11-02T19:43:00Z Snapshot: 089dcbc8ce7cfadb793c3521bfe9108cd9490c4fdd1686f3545376482651099e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1295976/explain?concept=fundies%3AOperatingCashFlow&period=2010-02-28&surface=latest&period_type=duration&start=2009-03-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 55192165 USD (2009-03-01 to 2010-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295976/0001193125-10-101417.txt#7215 The citation records this snapshot. The page link may show a newer release later.	USD 26.99 million Exact value Exact value: 26993044 USD 2009-03-01 – 2010-02-28: 26993044 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Cellu Tissue Holdings, Inc. · 2010-02-28 Cellu Tissue Holdings, Inc. (edgar:1295976) Capital Expenditure: 26993044 USD Concept: fundies:CapitalExpenditure Period: 2009-03-01 to 2010-02-28 Values: Latest reported Published: 2026-11-02T19:43:00Z Snapshot: 089dcbc8ce7cfadb793c3521bfe9108cd9490c4fdd1686f3545376482651099e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1295976/explain?concept=fundies%3ACapitalExpenditure&period=2010-02-28&surface=latest&period_type=duration&start=2009-03-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 26993044 USD (2009-03-01 to 2010-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295976/0001193125-10-101417.txt#7257 The citation records this snapshot. The page link may show a newer release later.	USD 28.2 million Calculation and evidence 55192165 − 26993044 USD Exact free cash flow: 28199121 USD 2009-03-01 – 2010-02-28: 55192165 USD · Inspect Operating Cash Flow · Source 2009-03-01 – 2010-02-28: 26993044 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Cellu Tissue Holdings, Inc. · 2010-02-28 Cellu Tissue Holdings, Inc. (edgar:1295976) Free cash flow: 28199121 USD Concept: free-cash-flow Period: 2009-03-01 to 2010-02-28 Values: Latest reported Published: 2026-11-02T19:43:00Z Snapshot: 089dcbc8ce7cfadb793c3521bfe9108cd9490c4fdd1686f3545376482651099e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1295976?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 55192165 USD (2009-03-01 to 2010-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295976/0001193125-10-101417.txt#7215 Input fundies:CapitalExpenditure: 26993044 USD (2009-03-01 to 2010-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295976/0001193125-10-101417.txt#7257 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

33 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001295976, 1295976, edgar:1295976

Cellu Tissue Holdings, Inc.

Latest quarter

Revenue

Operating margin

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2010 2009-03-01 – 2010-02-28

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation